XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in- Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018   44,358,000      
Beginning balance at Dec. 31, 2018 $ 20,952 $ 4 $ 75,942 $ (54,994) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 489   489    
Net Income (loss) (5,286)     (5,286)  
Ending balance (in shares) at Mar. 31, 2019   44,358,000      
Ending balance at Mar. 31, 2019 16,155 $ 4 76,431 (60,280) 0
Beginning balance (in shares) at Dec. 31, 2018   44,358,000      
Beginning balance at Dec. 31, 2018 20,952 $ 4 75,942 (54,994) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) 0        
Net Income (loss) (16,322)        
Ending balance (in shares) at Sep. 30, 2019   75,994,790      
Ending balance at Sep. 30, 2019 64,952 $ 8 136,260 (71,316) 0
Beginning balance (in shares) at Mar. 31, 2019   44,358,000      
Beginning balance at Mar. 31, 2019 16,155 $ 4 76,431 (60,280) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of options (in shares)   11,790      
Exercise of options 17   17    
Equity-based compensation 439   439    
Net Income (loss) (5,220)     (5,220)  
Ending balance (in shares) at Jun. 30, 2019   44,369,790      
Ending balance at Jun. 30, 2019 11,391 $ 4 76,887 (65,500) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 511   511    
Issuance of common stock (in shares)   31,625,000      
Issuance of common stock 58,866 $ 4 58,862    
Other comprehensive income (loss) 0        
Net Income (loss) (5,816)     (5,816)  
Ending balance (in shares) at Sep. 30, 2019   75,994,790      
Ending balance at Sep. 30, 2019 64,952 $ 8 136,260 (71,316) 0
Beginning balance (in shares) at Dec. 31, 2019   86,069,263      
Beginning balance at Dec. 31, 2019 80,747 $ 9 162,062 (81,297) (27)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 441   441    
Issuance of common stock (in shares)   1,081,184      
Issuance of common stock 2,766   2,766    
Other comprehensive income (loss) 10       10
Net Income (loss) 1,150     1,150  
Ending balance (in shares) at Mar. 31, 2020   87,150,447      
Ending balance at Mar. 31, 2020 85,114 $ 9 165,269 (80,147) (17)
Beginning balance (in shares) at Dec. 31, 2019   86,069,263      
Beginning balance at Dec. 31, 2019 $ 80,747 $ 9 162,062 (81,297) (27)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of options (in shares) 78,139        
Other comprehensive income (loss) $ 227        
Net Income (loss) (11,983)        
Ending balance (in shares) at Sep. 30, 2020   87,228,586      
Ending balance at Sep. 30, 2020 73,428 $ 9 166,499 (93,280) 200
Beginning balance (in shares) at Mar. 31, 2020   87,150,447      
Beginning balance at Mar. 31, 2020 85,114 $ 9 165,269 (80,147) (17)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of options (in shares)   55,899      
Exercise of options 50   50    
Equity-based compensation 544   544    
Other comprehensive income (loss) 355       355
Net Income (loss) (4,311)     (4,311)  
Ending balance (in shares) at Jun. 30, 2020   87,206,346      
Ending balance at Jun. 30, 2020 81,752 $ 9 165,863 (84,458) 338
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of options (in shares)   22,240      
Exercise of options 19   19    
Equity-based compensation 617   617    
Other comprehensive income (loss) (138)       (138)
Net Income (loss) (8,822)     (8,822)  
Ending balance (in shares) at Sep. 30, 2020   87,228,586      
Ending balance at Sep. 30, 2020 $ 73,428 $ 9 $ 166,499 $ (93,280) $ 200